Status:
RECRUITING
The Safety of Ropivacaine TAP Block Combined With Intravenous Lidocaine in Patients Undergoing Colorectal Cancer Surgery
Lead Sponsor:
West China Hospital
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Many studies have confirmed the analgesic effect of intravenous infusion of lidocaine in abdominal surgery. Transversus abdominis plane (TAP) block is also often recommended for abdominal surgery. Rop...
Detailed Description
Transversus abdominis plane (TAP) block is often recommended for abdominal surgery. Ropivacaine TAP block and intravenous lidocaine infusion are important components of multimodal analgesia for colore...
Eligibility Criteria
Inclusion
- Aged between 18 and 65 years;
- Patients who plan to undergo open/laparoscopic colorectal cancer resection surgery under general anesthesia;
- American society of Anesthesiologists (ASA) physical status classification system I\~II;
Exclusion
- Weight less than 40kg or more than 100kg;
- Defects in the cardiac conduction system (II or III degree atrioventricular block) or cardiac dysfunction (LVEF\<50%);
- Severe liver dysfunction (ALT, AST, bilirubin 2.5 times higher than normal), renal dysfunction (creatinine clearance rate\<60ml/min);
- Allergies to experimental drugs;
- Patients who are unable to communicate;
- Participating in other clinical researchers.
Key Trial Info
Start Date :
August 28 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 20 2024
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT06006026
Start Date
August 28 2023
End Date
May 20 2024
Last Update
April 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
West China hospital
Chengdu, China